nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADHD Combined Survey Results
|
|
|
2000 |
|
1_suppl |
p. 116-128 |
artikel |
2 |
ADHD Medication Survey
|
|
|
2000 |
|
1_suppl |
p. 35-85 |
artikel |
3 |
ADHD Psychosocial Survey
|
|
|
2000 |
|
1_suppl |
p. 86-115 |
artikel |
4 |
Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder
|
Biederman, J. |
|
2002 |
|
1_suppl |
p. 7-16 |
artikel |
5 |
Editorial
|
Greenhill, L. |
|
2002 |
|
1_suppl |
p. 3-6 |
artikel |
6 |
Foreword
|
Conners, C. K. |
|
2002 |
|
1_suppl |
p. 1 |
artikel |
7 |
Forty years of methylphenidate treatment in Attention-Deficit/Hyperactivity Disorder
|
Conners, C. K. |
|
2002 |
|
1_suppl |
p. 17-30 |
artikel |
8 |
Guideline 2: Assessment
|
|
|
2000 |
|
1_suppl |
p. 17-18 |
artikel |
9 |
Guideline 6: Changing the Treatment Regimen When Patient Has an Inadequate Response or Intolerable Side Effects
|
|
|
2000 |
|
1_suppl |
p. 29-30 |
artikel |
10 |
Guideline 1: Diagnosis
|
|
|
2000 |
|
1_suppl |
p. 14-16 |
artikel |
11 |
Guideline 10: Improving Treatment for ADHD27
|
|
|
2000 |
|
1_suppl |
p. 34 |
artikel |
12 |
Guideline 9: Level of Care: Maintenance Treatment26
|
|
|
2000 |
|
1_suppl |
p. 33 |
artikel |
13 |
Guideline 8: No Response or Persistently Refractory to Treatment
|
|
|
2000 |
|
1_suppl |
p. 32 |
artikel |
14 |
Guideline 7: Partial Response to Treatment
|
|
|
2000 |
|
1_suppl |
p. 31 |
artikel |
15 |
Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder
|
Greenhill, L. |
|
2002 |
|
1_suppl |
p. 89-100 |
artikel |
16 |
Guideline 4: Selecting Initial Medication
|
|
|
2000 |
|
1_suppl |
p. 21-24 |
artikel |
17 |
Guideline 5: Selecting Initial Psychosocial Interventions
|
|
|
2000 |
|
1_suppl |
p. 25-28 |
artikel |
18 |
Guideline 3: Selecting Overall Treatment Strategy: Psychosocial Interventions, Medication, or a Combination of Both
|
|
|
2000 |
|
1_suppl |
p. 19-20 |
artikel |
19 |
Is there stimulant sensitivity in children?
|
Klein, R. |
|
2002 |
|
1_suppl |
p. 61-63 |
artikel |
20 |
Longer term effects of stimulant treatments for Attention-Deficit/Hyperactivity Disorder
|
Jensen, P. |
|
2002 |
|
1_suppl |
p. 45-56 |
artikel |
21 |
Mechanism of action of methylphenidate: Insights from PET imaging studies
|
Volkow, N. D. |
|
2002 |
|
1_suppl |
p. 31-43 |
artikel |
22 |
Methylphenidate and substance abuse: A review of pharmacology, animal, and clinical studies
|
Huss, M. |
|
2002 |
|
1_suppl |
p. 65-71 |
artikel |
23 |
Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder
|
Biederman, J. |
|
2002 |
|
1_suppl |
p. 101-107 |
artikel |
24 |
Non-stimulant treatment for Attention-Deficit/Hyperactivity Disorder
|
Spencer, T. |
|
2002 |
|
1_suppl |
p. 109-119 |
artikel |
25 |
Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: Update 2002
|
Rapoport, J. L. |
|
2002 |
|
1_suppl |
p. 57-60 |
artikel |
26 |
The Expert Consensus Panels for ADHD
|
|
|
2000 |
|
1_suppl |
p. 5-6 |
artikel |
27 |
The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications
|
Swanson, J. M. |
|
2002 |
|
1_suppl |
p. 73-88 |
artikel |
28 |
Treatment of Attention-Deficit/Hyperactivity Disorder: Expert Consensus Guidelines
|
Conners, C.K. |
|
2000 |
|
1_suppl |
p. 7-13 |
artikel |